Skip to main content

Table 4 Logistic regression analysis (survivors)

From: Impact of individual background on the unmet needs of cancer survivors and caregivers – a mixed-methods analysis

 Odds ratio (95% Confidence interval)
 PhysicalFinancialEducation/informationPersonal ControlSystem of CareResources
Sex
 Male (reference)
 Female2.50 (1.54–4.07)*0.52 (0.22–1.21)0.79 (0.54–1.15)1.95 (0.59–6.42)1.19 (0.47–3.05)0.62 (0.43–0.91)*
Age group (in years)
< 40, 40–59, 60–69, ≥ 701.25 (1.00–1.57)1.03 (0.70–1.51)0.94 (0.78–1.13)0.80 (0.46–1.39)0.77 (0.49–1.22)0.98 (0.81–1.18)
Cancer type
Breast (reference)
 Colon1.05 (0.52–2.10)0.52 (0.15–1.81)1.11 (0.59–2.08)0.59 (0.07–5.12)1.99 (0.44–9.08)1.34 (0.70–2.60)
 Lung0.72 (0.31–1.69)0.15 (0.02–1.31)1.72 (0.87–3.43)0.78 (0.09–7.02)0.85 (0.09–7.93)1.39 (0.67–2.87)
 Stomach0.96 (0.44–2.10)0.27 (0.05–1.40)1.27 (0.63–2.58)1.94 (0.34–11.00)1.56 (0.26–9.24)1.49 (0.73–3.03)
 Other0.78 (0.45–1.33)0.53 (0.20–1.35)1.11 (0.69–1.81)1.17 (0.35–3.95)1.56 (0.47–5.20)1.23 (0.74–2.04)
 Multi primary2.33 (0.85–6.43)0.35 (0.04–2.94)0.49 (0.16–1.53)3.97 (0.67–23.40)1.95 (0.21–18.40)1.25 (0.47–3.31)
 Never diagnosed with cancer0.41 (0.17–0.97)*0.25 (0.06–0.98)*1.77 (1.00–3.13)0.00 (0.00-Inf)1.83 (0.47–7.20)1.40 (0.77–2.54)
Treatment course
Pretreatment (reference)
 Ongoing5.08 (2.64–9.78)*0.71 (0.32–1.59)1.28 (0.85–1.93)1.31 (0.43–3.96)0.70 (0.25–1.98)0.51 (0.34–0.78)*
 Completed5.35 (2.74–10.40)*0.91 (0.41–2.06)0.78 (0.52–1.18)0.28 (0.05–1.47)0.69 (0.26–1.80)0.68 (0.46–1.01)
Residence
CDOa (reference)
 Within KPb1.12 (0.74–1.70)0.85 (0.42–1.73)0.75 (0.53–1.07)1.19 (0.44–3.22)1.44 (0.64–3.25)1.16 (0.82–1.65)
 Outside KPb0.22 (0.06–0.79)*0.80 (0.18–3.58)0.90 (0.45–1.78)1.67 (0.34–8.25)0.64 (0.08–5.12)1.51 (0.78–2.95)
Symptom
Yes (reference)
 No8.69 (5.35–14.10)*0.67 (0.35–1.29)0.46 (0.33–0.64)*0.99 (0.38–2.59)0.79 (0.35–1.76)0.69 (0.50–0.96)*
Past consultation history at KCCc
 Yes (reference)
 No1.22 (0.65–2.28)1.91 (0.75–4.81)1.18 (0.68–2.06)0.53 (0.07–4.16)0.91 (0.21–4.00)0.54 (0.27–1.07)
 Emotions/Mental HealthSocial SupportCommunicationsProvider RelationshipCureEmployment
Sex
 Male (reference)      
 Female1.60 (1.05–2.43)*1.76 (0.38–8.23)1.81 (0.80–4.08)1.25 (0.72–2.17)0.77 (0.51–1.15)0.34 (0.10–1.21)
Age group (in years)      
  < 40, 40–59, 60–69, ≥ 700.95 (0.78–1.16)1.30 (0.69–2.47)1.18 (0.82–1.70)0.98 (0.75–1.29)1.03 (0.84–1.25)0.37 (0.20–0.67)*
Cancer type
 Breast (reference)      
 Colon0.83 (0.43–1.62)0.00 (0.00-Inf)1.28 (0.48–3.41)1.96 (0.86–4.48)1.03 (0.52–2.04)0.00 (0.00-Inf)
 Lung0.73 (0.33–1.61)0.00 (0.00-Inf)0.46 (0.10–2.17)1.88 (0.73–4.83)1.46 (0.71–3.02)0.27 (0.02–2.86)
 Stomach0.93 (0.45–1.93)0.41 (0.04–4.15)0.46 (0.10–2.20)1.17 (0.41–3.31)1.13 (0.53–2.42)0.17 (0.02–1.86)
 Other0.91 (0.56–1.47)0.43 (0.10–1.88)0.63 (0.26–1.49)1.16 (0.57–2.36)1.14 (0.68–1.92)0.61 (0.19–1.98)
 Multi primary0.89 (0.33–2.40)2.03 (0.32–13.00)2.00 (0.57–7.00)1.84 (0.55–6.18)0.98 (0.35–2.73)0.00 (0.00-Inf)
 Never diagnosed with cancer1.52 (0.85–2.71)0.27 (0.03–2.58)0.31 (0.07–1.45)1.43 (0.59–3.44)1.01 (0.53–1.93)0.00 (0.00-Inf)
Treatment course
 Pretreatment (reference)      
 Ongoing1.14 (0.72–1.79)1.36 (0.32–5.78)1.48 (0.66–3.31)1.63 (0.86–3.09)0.97 (0.63–1.48)1.01 (0.29–3.55)
 Completed1.23 (0.79–1.91)1.42 (0.31–6.46)0.68 (0.26–1.73)1.26 (0.66–2.42)0.53 (0.34–0.82)*2.72 (0.86–8.57)
Residence
 CDOa (reference)      
 Within KPb1.18 (0.82–1.70)0.30 (0.07–1.38)1.20 (0.63–2.30)1.18 (0.71–1.94)1.20 (0.83–1.74)1.03 (0.41–2.58)
 Outside KPb0.79 (0.35–1.79)1.01 (0.12–8.62)0.39 (0.05–3.02)0.85 (0.29–2.54)1.92 (0.98–3.75)0.00 (0.00-Inf)
Symptom
 Yes (reference)      
 No1.78 (1.25–2.53)*1.21 (0.41–3.61)1.31 (0.70–2.46)1.49 (0.92–2.42)0.56 (0.40–0.79)*1.59 (0.62–4.10)
Past consultation history at KCCc
 Yes (reference)      
 No0.85 (0.47–1.55)0.00 (0.00-Inf)1.13 (0.42–3.03)0.62 (0.24–1.60)0.31 (0.13–0.74)*0.44 (0.05–3.48)
  1. *p < 0.05, aA city designated by official ordinance, bKanagawa prefecture, cKanagawa Cancer Center
\